Ketosurg Tablet contains Alpha Ketoanalogue (NA), a specialized nutritional supplement used primarily in the management of chronic kidney disease (CKD). Alpha Ketoanalogues are nitrogen-free analogues of essential amino acids that play a critical role in reducing nitrogenous waste accumulation and minimizing uremic symptoms in patients with impaired renal function. Ketosurg Tablet is indicated as an adjunct to a low-protein diet in patients with moderate to severe renal insufficiency to help maintain nutritional status while reducing the burden on compromised kidneys. By providing essential amino acid precursors without contributing to nitrogen load, Ketosurg supports protein synthesis and helps prevent malnutrition and muscle wasting commonly associated with CKD. The tablet is typically administered orally with meals, with dosage tailored according to the patient’s renal function, dietary protein intake, and clinical condition. Ketosurg is contraindicated in patients with hypersensitivity to any component of the formulation and should be used cautiously in those with hepatic impairment. Adverse effects are generally mild and may include gastrointestinal discomfort or allergic reactions. Regular monitoring of renal function, nutritional parameters, and metabolic status is recommended during therapy to optimize treatment outcomes. Ketosurg Tablet should be used under medical supervision as part of a comprehensive renal care plan.